Background
Discontinuation of drug therapy is an important intervention in elderly outpatients receiving multiple medications, but it may be associated with adverse drug withdrawal events (ADWEs).
Objective
To determine the frequency, types, timing, severity, and factors associated with ADWEs after discontinuing medications in elderly outpatients.
Patients
One hundred twenty-four ambulatory elderly participants in 1-year health service intervention trial at the Durham Veterans Affairs General Medicine Clinic in Durham, NC, who stopped taking medications.
Methods
A geriatrician retrospectively reviewed computerized medication records and clinical charts to determine medications no longer being taken and adverse events in the subsequent 4-month period. Possible ADWEs, determined by using the Naranjo causality algorithm, were categorized by therapeutic class, organ system, and severity.
Results
Of 238 drugs stopped, 62 (26%) resulted in 72 ADWEs among 38 patients. Cardiovascular (42%) and central nervous system (18%) drug classes were most frequently associated with ADWEs. The ADWEs most commonly involved the circulatory (51%) and central nervous (13%) systems, and 88% were attributed to exacerbations of underlying disease. Twenty-six ADWEs (36%) resulted in hospitalization or an emergency department or urgent care clinic visit. Only the number of medications stopped was associated with ADWE occurrence (adjusted odds ratio, 1.89; 95% confidence interval, 1.33-2.67).
Conclusions
Most medications can be stopped in elderly outpatients without an ADWE occurrence. However, when ADWEs occur they resulted in substantial health care utilization. Practitioners should strive to discontinue drug therapy in the elderly but be vigilant for disease recurrence.
Arch Intern Med. 1997;157:2205-2210
Drug Discontinuation Effects Are Part of the Pharmacology of a Drug
Reidenberg
J. Pharmacol. Exp. Ther. 2011;339:324-328.
ABSTRACT
| FULL TEXT
Association of ICU or Hospital Admission With Unintentional Discontinuation of Medications for Chronic Diseases
Bell et al.
JAMA 2011;306:840-847.
ABSTRACT
| FULL TEXT
A pilot randomized controlled trial of deprescribing
Beer et al.
Therapeutic Advances in Drug Safety 2011;2:37-43.
ABSTRACT
Managing Medications in Clinically Complex Elders: "There's Got to Be a Happy Medium"
Steinman and Hanlon
JAMA 2010;304:1592-1601.
ABSTRACT
| FULL TEXT
Appropriate Discontinuation of Medications at the End of Life: A Need to Establish Consensus Criteria
Lee et al.
American Journal of Medical Quality 2007;22:393-394.
The Utility of Adding Retrospective Medication Profiling to Computerized Provider Order Entry in an Ambulatory Care Population
Glassman et al.
J Am Med Inform Assoc 2007;14:424-431.
ABSTRACT
| FULL TEXT
The broader implications of diabetes management at the end of life
Currow and Abernethy
Palliat Med 2006;20:638-639.
Reconsidering medication appropriateness for patients late in life.
Holmes et al.
Arch Intern Med 2006;166:605-609.
FULL TEXT
Risk of adverse drug events by patient destination after hospital discharge
Triller et al.
Am J Health Syst Pharm 2005;62:1883-1889.
ABSTRACT
| FULL TEXT
Patient Safety in Guideline-Based Decision Support for Hypertension Management: ATHENA DSS
Goldstein et al.
J Am Med Inform Assoc 2002;9:S11-S16.
ABSTRACT
| FULL TEXT
Polypharmacy in Elderly Patients With Diabetes
Good
Diabetes Spectr. 2002;15:240-248.
ABSTRACT
| FULL TEXT
Coming of Age
Boyer
Arch Intern Med 1997;157:2173-2173.
ABSTRACT
